Comparability preview
Build the board report — $49 →
Transcelerate Biopharma Inc
EIN 460886344 · PA · NTEE H99 · revenue $34,168,812 · FY 2023-12-31
$
Pick the role and type the pay your board is considering — everything below updates as you type. We only compare against the same role.
100th percentile
We compared this Executive Director / CEO's pay to 24 similar medical research nonprofits of about the same size, adjusted for PA cost of living and inflation.
DALVIR GILL · reported title "FORMER CEO".
How we chose them
Every comparable organization in the band — 24 in total — matched by Same NTEE major group (H), nationwide + budget 0.77–1.3× revenue, and selected by rule, not hand-picked. Peer pay is normalized to PA cost of living (BEA Regional Price Parities) and to the subject's filing year (CPI-U). Full methodology →
| Organization | State | Revenue | Total comp | Filing |
|---|---|---|---|---|
| Max Planck Florida Corporation | FL | $33,505,675 | $497,742 | 990 → |
| American Urological Association | MD | $35,355,221 | $599,411 | 990 → |
| Nrg Oncology Foundation Inc | PA | $32,205,558 | $14,948 | 990 → |
| Wills Eye Ophthalmology | PA | $31,970,742 | $256,175 | 990 → |
| Bliss Cares Inc | FL | $36,602,971 | $178,847 | 990 → |
| 🔒 +19 more comparable organizations — the full peer set, sources, and CSV export are included in your board report. | ||||
Generate the board-ready determination
A formatted PDF with the full 24-organization peer set, the distribution, the methodology, and ready-to-adopt 26 CFR 53.4958-6 board-minutes language — timestamped to attach to your minutes. A screenshot of a webpage isn't board minutes.